ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 78 filers reported holding ODONATE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $150,000 | -81.4% | 44,000 | +4.8% | 0.00% | -100.0% |
| Q4 2020 | $806,000 | +42.9% | 42,000 | 0.0% | 0.00% | – |
| Q3 2020 | $564,000 | -53.4% | 42,000 | +46.9% | 0.00% | -100.0% |
| Q2 2020 | $1,211,000 | +58.3% | 28,600 | +3.2% | 0.00% | 0.0% |
| Q1 2020 | $765,000 | -14.9% | 27,700 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $899,000 | +29.9% | 27,700 | +4.1% | 0.00% | 0.0% |
| Q3 2019 | $692,000 | +52.1% | 26,600 | +114.5% | 0.00% | – |
| Q2 2019 | $455,000 | – | 12,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $53,060,000 | 14.93% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $1,710,000 | 0.93% |
| Boxer Capital, LLC | 5,607,086 | $19,176,000 | 0.65% |
| Samsara BioCapital, LLC | 700,421 | $2,395,000 | 0.44% |
| SABBY MANAGEMENT, LLC | 634,728 | $2,171,000 | 0.42% |
| Prosight Management, LP | 117,621 | $402,000 | 0.33% |
| QCM Cayman, Ltd. | 15,478 | $53,000 | 0.16% |
| Ikarian Capital, LLC | 1,336,412 | $4,571,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 169,198 | $579,000 | 0.13% |
| Walleye Capital LLC | 273,000 | $934,000 | 0.05% |